{
    "targetDisease": "Chikungunya",
    "vaccineGroup": "Chikungunya",
    "contraindications": {
        "vaccineGroup": {
            "contraindication": [
                {
                    "observationCode": "080",
                    "observationTitle": "Adverse reaction to vaccine component",
                    "contraindicationText": "Do not vaccinate if the patient has had an adverse reaction to a vaccine component."
                },
                {
                    "observationCode": "270",
                    "observationTitle": "Severe allergic reaction after previous dose of Chikungunya vaccine",
                    "contraindicationText": "Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of Chikungunya vaccine."
                }
            ]
        }
    },
    "series": [
        {
            "seriesName": "Chikungunya Risk 1-dose series",
            "targetDisease": "Chikungunya",
            "vaccineGroup": "Chikungunya",
            "seriesAdminGuidance": [
                "On 8/22/2025 the US FDA's Center for Biologics Evaluation and Research (CBER) has suspended the biologics license for Valneva Austria GmbH's live-attenuated IXCHIQ vaccine. CBER's decision is based on serious safety concerns related to the vaccine, which appears to be causing chikungunya-like illness in vaccine recipients. There has been one death from encephalitis directly attributable to the vaccine.",
                "In general, vaccination of pregnant women should be deferred until after delivery. However, when the risk of infection is high (e.g., during an outbreak) and exposure cannot be avoided, a healthcare provider and pregnant woman should discuss the risks of chikungunya virus infection and the potential benefits and risks of vaccination"
            ],
            "seriesType": "Risk",
            "selectSeries": {
                "defaultSeries": "No",
                "productPath": "No",
                "seriesGroupName": "Increased Risk",
                "seriesGroup": "1",
                "seriesPriority": "A",
                "seriesPreference": "1",
                "minAgeToStart": "12 years"
            },
            "indication": [
                {
                    "observationCode": {
                        "text": "Traveling to a country or territory where there is a chikungunya outbreak",
                        "code": "271"
                    },
                    "description": "Administer to persons traveling to a country or territory where there is a chikungunya outbreak",
                    "beginAge": "12 years",
                    "guidance": "Areas with a current Chikungunya outbreak: https://www.cdc.gov/chikungunya/data-maps/index.html"
                },
                {
                    "observationCode": {
                        "text": "Traveling or moving to a country or territory without an outbreak but with elevated chikungunya risk for U.S. travelers if planning to stay for an extended period of time [e.g., 6 months or more]",
                        "code": "272"
                    },
                    "description": "Persons traveling or moving to a country or territory without an outbreak but with elevated chikungunya risk for U.S. travelers if planning to stay for an extended period of time [e.g., 6 months or more] may consider vaccination",
                    "beginAge": "12 years",
                    "guidance": "Areas with an elevated risk for U.S. travelers: https://www.cdc.gov/chikungunya/data-maps/index.html"
                },
                {
                    "observationCode": {
                        "text": "Laboratory worker with potential for exposure to chikungunya virus",
                        "code": "277"
                    },
                    "description": "Administer to laboratory workers with potential for exposure to chikungunya virus",
                    "beginAge": "12 years"
                }
            ],
            "seriesDose": [
                {
                    "doseNumber": "Dose 1",
                    "age": [
                        {
                            "absMinAge": "12 years - 4 days",
                            "minAge": "12 years",
                            "earliestRecAge": "12 years"
                        }
                    ],
                    "preferableVaccine": [
                        {
                            "vaccineType": "Chikungunya, VLP, recombinant, 0.8 mL, PF",
                            "cvx": "329",
                            "beginAge": "12 years",
                            "volume": "0.8",
                            "forecastVaccineType": "N"
                        }
                    ],
                    "allowableVaccine": [
                        {
                            "vaccineType": "Chikungunya live attenuated vaccine, 0.5 mL, PF",
                            "cvx": "317",
                            "beginAge": "18 years - 4 days"
                        },
                        {
                            "vaccineType": "Chikungunya, VLP, recombinant, 0.8 mL, PF",
                            "cvx": "329",
                            "beginAge": "12 years - 4 days"
                        }
                    ],
                    "recurringDose": "No"
                }
            ]
        }
    ]
}